See more : FAIRCOURT GOLD INCOME CORP. (FGX.NE) Income Statement Analysis – Financial Results
Complete financial analysis of Adcock Ingram Holdings Limited (AIP.JO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Adcock Ingram Holdings Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Genius Metals Inc. (GNSMF) Income Statement Analysis – Financial Results
- Force Motors Limited (FORCEMOT.BO) Income Statement Analysis – Financial Results
- PCAS SA (PCA.PA) Income Statement Analysis – Financial Results
- IG Group Holdings plc (IGGRF) Income Statement Analysis – Financial Results
- National Medical Care Company (4005.SR) Income Statement Analysis – Financial Results
Adcock Ingram Holdings Limited (AIP.JO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.adcock.co.za
About Adcock Ingram Holdings Limited
Adcock Ingram Holdings Limited manufactures, markets, and distributes healthcare products in South Africa, the United States, Canada, the United Kingdom, rest of Europe, and internationally. It offers a portfolio of over the counter products, prescription medicines, and consumer products, as well as instrumentation and surgical products. The company also provides pharmaceutical products in a range of therapeutic classes, such as women's health, cannabidiol, antiretroviral, dermatology, central nervous system, respiratory, ophthalmology, generics, cardiovascular, pain, gastroenterology, energy supplements, colds and flu, personal care, feminine hygiene, digestive well-being, allergies, baby care, cough, food and nutrition supplements, vitamins, and minerals supplements. In addition, it manufactures and supplies hospital and critical care products, including intravenous solutions, renal dialysis systems, and blood collection products. The company serves private and public sectors. Adcock Ingram Holdings Limited was founded in 1890 and is headquartered in Midrand, South Africa.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.64B | 9.13B | 8.71B | 7.78B | 7.35B | 7.08B | 6.54B | 5.94B | 5.55B | 5.53B | 4.95B | 5.45B | 4.60B | 4.45B | 4.44B | 4.12B | 3.53B | 2.88B | 3.83B | 3.32B |
| Cost of Revenue | 6.46B | 5.94B | 5.65B | 5.09B | 4.61B | 4.29B | 3.97B | 3.69B | 3.52B | 3.45B | 3.46B | 3.21B | 2.51B | 2.28B | 2.11B | 1.97B | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 3.18B | 3.19B | 3.06B | 2.68B | 2.74B | 2.79B | 2.57B | 2.24B | 2.03B | 2.08B | 1.49B | 2.24B | 2.09B | 2.17B | 2.33B | 2.15B | 3.53B | 2.88B | 3.83B | 3.32B |
| Gross Profit Ratio | 33.02% | 34.90% | 35.12% | 34.50% | 37.28% | 39.40% | 39.23% | 37.77% | 36.60% | 37.65% | 30.16% | 41.08% | 45.53% | 48.70% | 52.58% | 52.17% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 104.94M | 81.60M | 70.72M | 65.29M | 64.47M | 33.07M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 207.30M | 76.62M | 69.27M | 555.68M | 531.05M | 514.86M | 511.40M | 449.28M | 419.29M | 396.15M | 562.24M | 329.53M | 363.54M | 292.61M | 405.60M | 375.62M | 12.33M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 812.85M | 838.39M | 824.11M | 1.21B | 1.26B | 1.32B | 1.19B | 1.07B | 1.00B | 1.12B | 982.99M | 911.57M | 780.13M | 736.99M | 663.64M | 552.00M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.02B | 915.01M | 893.38M | 1.21B | 1.26B | 1.32B | 1.19B | 1.07B | 1.00B | 1.12B | 1.55B | 911.57M | 1.14B | 1.03B | 1.07B | 927.61M | 12.33M | 0.00 | 0.00 | 0.00 |
| Other Expenses | 1.10B | -844.00K | 1.09B | 573.64M | 531.99M | 556.61M | -7.32M | -6.25M | -3.89M | -15.26M | 0.00 | 329.53M | 26.87M | 16.89M | 10.65M | 0.00 | 404.29M | -1.94B | -2.59B | -2.08B |
| Operating Expenses | 2.12B | 2.05B | 1.99B | 1.79B | 1.80B | 1.88B | 1.73B | 1.56B | 1.46B | 1.65B | 2.35B | 1.35B | 1.23B | 1.10B | 1.13B | 992.09M | 449.68M | -1.94B | -2.59B | -2.08B |
| Cost & Expenses | 8.58B | 8.00B | 7.63B | 6.88B | 6.40B | 6.16B | 5.71B | 5.25B | 4.98B | 5.09B | 5.81B | 4.55B | 3.73B | 3.38B | 3.24B | 2.96B | 449.68M | -1.94B | -2.59B | -2.08B |
| Interest Income | 10.70M | 6.85M | 3.54M | 4.32M | 3.98M | 6.19M | 18.23M | 14.73M | 3.07M | 15.79M | 91.40M | 24.53M | 18.29M | 63.78M | 59.29M | 100.49M | 11.04M | 56.70M | 17.09M | 0.00 |
| Interest Expense | 97.46M | 59.66M | 45.40M | 47.98M | 38.74M | 17.69M | 23.52M | 33.63M | 74.40M | 99.03M | 0.00 | 82.50M | 26.64M | 30.23M | 40.47M | 100.49M | 67.67M | 135.80M | 112.40M | 315.03M |
| Depreciation & Amortization | 200.61M | 198.03M | 192.66M | 195.14M | 195.49M | 162.43M | 160.18M | 150.07M | 148.07M | 196.10M | 209.53M | 39.81M | 45.16M | 105.25M | 101.59M | 110.11M | 7.04M | 56.70M | -36.56M | -1.74M |
| EBITDA | 1.42B | 1.34B | 1.25B | 1.05B | 1.07B | 1.06B | 985.84M | 828.83M | 772.40M | 710.94M | -4.20M | 1.00B | 913.98M | 1.25B | 1.10B | 1.24B | 528.62M | 1.00B | 1.21B | 1.36B |
| EBITDA Ratio | 14.76% | 14.84% | 14.37% | 12.85% | 16.76% | 16.52% | 16.71% | 15.31% | 14.08% | 12.86% | -0.08% | 17.09% | 19.87% | 28.17% | 30.89% | 28.06% | 14.29% | 34.76% | 31.52% | 37.39% |
| Operating Income | 1.06B | 1.14B | 1.05B | 849.76M | 862.18M | 883.54M | 819.48M | 677.30M | 553.25M | 344.66M | -213.72M | 890.81M | 868.82M | 1.07B | 1.20B | 1.04B | 497.61M | 944.10M | 1.24B | 1.24B |
| Operating Income Ratio | 11.04% | 12.43% | 12.09% | 10.93% | 11.74% | 12.48% | 12.53% | 11.41% | 9.98% | 6.23% | -4.32% | 16.36% | 18.89% | 24.00% | 27.03% | 25.39% | 14.09% | 32.79% | 32.47% | 37.44% |
| Total Other Income/Expenses | 60.00M | 70.06M | 49.17M | 56.12M | 67.83M | 82.93M | -2.79M | 47.55M | -3.31M | -7.26M | -735.07M | -45.90M | 18.52M | 50.44M | -239.54M | -8.11M | -574.69M | -124.90M | -148.72M | -225.46M |
| Income Before Tax | 1.12B | 1.21B | 1.10B | 905.88M | 930.01M | 966.47M | 895.16M | 724.84M | 549.93M | 339.84M | -948.80M | 848.11M | 887.34M | 1.12B | 960.76M | 1.04B | 429.94M | 819.20M | 1.10B | 1.02B |
| Income Before Tax Ratio | 11.66% | 13.20% | 12.66% | 11.65% | 12.66% | 13.65% | 13.69% | 12.21% | 9.92% | 6.15% | -19.17% | 15.57% | 19.29% | 25.13% | 21.64% | 25.19% | 12.17% | 28.45% | 28.59% | 30.65% |
| Income Tax Expense | 310.81M | 307.22M | 301.27M | 243.76M | 247.82M | 269.44M | 251.08M | 204.86M | 170.55M | 141.03M | 38.97M | 246.88M | 168.27M | 326.13M | 317.54M | -1.04B | -447.73M | 241.10M | 296.90M | 243.04M |
| Net Income | 814.01M | 898.41M | 800.35M | 657.46M | 676.37M | 687.99M | 637.94M | 553.53M | 168.80M | 197.93M | -914.15M | 587.84M | 705.64M | 764.80M | 643.23M | 789.88M | 324.73M | 570.40M | 789.13M | 769.09M |
| Net Income Ratio | 8.44% | 9.84% | 9.19% | 8.45% | 9.21% | 9.72% | 9.75% | 9.32% | 3.04% | 3.58% | -18.47% | 10.79% | 15.34% | 17.17% | 14.48% | 19.19% | 9.20% | 19.81% | 20.60% | 23.18% |
| EPS | 5.40 | 5.61 | 4.95 | 3.96 | 3.98 | 4.14 | 3.84 | 3.33 | 1.01 | 1.17 | -5.42 | 3.49 | 4.18 | 4.59 | 3.64 | 4.51 | 3.79 | 3.25 | 4.58 | 4.46 |
| EPS Diluted | 5.26 | 5.49 | 4.86 | 3.96 | 3.98 | 4.14 | 3.84 | 3.33 | 1.01 | 1.17 | -5.42 | 3.48 | 4.17 | 4.58 | 3.63 | 4.50 | 3.76 | 3.23 | 4.48 | 4.37 |
| Weighted Avg Shares Out | 150.84M | 160.06M | 161.76M | 165.89M | 169.93M | 166.26M | 166.29M | 166.29M | 166.48M | 168.83M | 168.63M | 168.62M | 168.89M | 170.70M | 173.71M | 173.21M | 172.55M | 172.40M | 172.40M | 172.40M |
| Weighted Avg Shares Out (Dil) | 154.63M | 163.75M | 164.77M | 165.97M | 169.95M | 166.26M | 166.30M | 166.29M | 166.48M | 168.84M | 168.63M | 168.75M | 169.13M | 171.05M | 174.10M | 173.81M | 173.65M | 173.40M | 176.00M | 176.00M |
Source: https://incomestatements.info
Category: Stock Reports